Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

New functions assigned to a microRNA with genetic links to prostate cancer risk.

Kurozumi A, Lupold SE.

Ann Transl Med. 2019 Sep;7(Suppl 6):S193. doi: 10.21037/atm.2019.07.29. No abstract available.

2.

Development of a novel method for visualizing restricted diffusion using subtraction of apparent diffusion coefficient values.

Yoshimura Y, Kuroda M, Sugianto I, Khasawneh A, Bamgbose BO, Hamada K, Barham M, Tekiki N, Kurozumi A, Matsushita T, Ohno S, Kanazawa S, Asaumi J.

Mol Med Rep. 2019 Sep;20(3):2963-2969. doi: 10.3892/mmr.2019.10523. Epub 2019 Jul 25.

PMID:
31524240
3.

Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes.

Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, Nishida K, Shiraiwa T, Torimoto K, Kurozumi A, Wakasugi S, Gosho M, Shimomura I, Watada H.

Diabetes Ther. 2019 Oct;10(5):1565-1575. doi: 10.1007/s13300-019-0665-8. Epub 2019 Jul 23.

4.

Efficacy and Safety of Tofogliflozin on 24-h Glucose Profile Based on Continuous Glucose Monitoring: Crossover Study of Sodium-Glucose Cotransporter 2 Inhibitor.

Kurozumi A, Okada Y, Shimokawa M, Goshima Y, Otsuka T, Narisawa M, Torimoto K, Tanaka Y.

Diabetes Technol Ther. 2019 Jul;21(7):385-392. doi: 10.1089/dia.2019.0099. Epub 2019 Jun 17.

PMID:
31210529
5.

IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2.

Kurozumi A, Nakano K, Yamagata K, Okada Y, Nakayamada S, Tanaka Y.

Bone. 2019 Jul;124:53-61. doi: 10.1016/j.bone.2019.04.006. Epub 2019 Apr 11.

PMID:
30981888
6.

Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring.

Hajime M, Okada Y, Mori H, Uemura F, Sonoda S, Tanaka K, Kurozumi A, Narisawa M, Torimoto K, Tanaka Y.

Diabetol Metab Syndr. 2019 Feb 15;11:18. doi: 10.1186/s13098-019-0412-3. eCollection 2019.

7.

Effects of the loss and reconstruction of molar occlusal support on memory retrieval and hippocampal neuron density in rats.

Kurozumi A, Hara T, Sakamoto S, Araki D, Iida-Tamada S, Kuroda-Ishimine C, Minagi S.

J Prosthodont Res. 2019 Jul;63(3):283-287. doi: 10.1016/j.jpor.2018.12.009. Epub 2019 Jan 25.

PMID:
30686619
8.

[Improvement of Brain Contrast Using Spin Echo T1-weighted Image at 3 T MRI].

Matsushita T, Fujii S, Kurozumi A, Nagano A, Ichiba Y, Ohno S, Tahara S.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(1):46-53. doi: 10.6009/jjrt.2019_JSRT_75.1.46. Japanese.

9.

Glycemic Profiling in Patients with Drug-Naïve Type 2 Diabetes by Continuous Glucose Monitoring.

Mori H, Okada Y, Kawaguchi M, Otsuka T, Miyazaki M, Sonoda S, Sugai K, Uemura F, Tanaka K, Hajime M, Kurozumi A, Narisawa M, Torimoto K, Tanaka Y.

J UOEH. 2018;40(4):287-297. doi: 10.7888/juoeh.40.287.

10.

PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.

Zennami K, Choi SM, Liao R, Li Y, Dinalankara W, Marchionni L, Rafiqi FH, Kurozumi A, Hatano K, Lupold SE.

Mol Cancer Res. 2019 Feb;17(2):618-627. doi: 10.1158/1541-7786.MCR-18-0837. Epub 2018 Dec 5.

PMID:
30518628
11.

Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.

Arai T, Okato A, Yamada Y, Sugawara S, Kurozumi A, Kojima S, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Cancer Med. 2018 May;7(5):1988-2002. doi: 10.1002/cam4.1455. Epub 2018 Apr 2.

12.

Association Between Diabetic Microangiopathies and Glycemic Variability Assessed by Continuous Glucose Monitoring.

Sonoda S, Okada Y, Mori H, Uemura F, Sugai K, Hajime M, Tanaka K, Kurozumi A, Narisawa M, Torimoto K, Tanaka Y.

J UOEH. 2018;40(1):11-18. doi: 10.7888/juoeh.40.11.

14.

Molecular pathogenesis of interstitial cystitis based on microRNA expression signature: miR-320 family-regulated molecular pathways and targets.

Arai T, Fuse M, Goto Y, Kaga K, Kurozumi A, Yamada Y, Sugawara S, Okato A, Ichikawa T, Yamanishi T, Seki N.

J Hum Genet. 2018 May;63(5):543-554. doi: 10.1038/s10038-018-0419-x. Epub 2018 Mar 12.

PMID:
29531336
15.

The Usefulness of Readout-Segmented Echo-Planar Imaging (RESOLVE) for Bio-phantom Imaging Using 3-Tesla Clinical MRI.

Yoshimura Y, Kuroda M, Sugiantoc I, Bamgbosec BO, Miyahara K, Ohmura Y, Kurozumi A, Matsushita T, Ohno S, Kanazawa S, Asaumi J.

Acta Med Okayama. 2018 Feb;72(1):53-59. doi: 10.18926/AMO/55663.

16.

Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1.

Kurozumi A, Okada Y, Satoh H, Inoue I, Chimori H, Akita E, Shiraiwa T, Fujitani Y, Mita T, Gosho M, Watada H.

Endocr J. 2018 Apr 26;65(4):415-425. doi: 10.1507/endocrj.EJ17-0386. Epub 2018 Jan 25.

17.

Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.

Okato A, Arai T, Yamada Y, Sugawara S, Koshizuka K, Fujimura L, Kurozumi A, Kato M, Kojima S, Naya Y, Ichikawa T, Seki N.

Int J Mol Sci. 2017 Sep 13;18(9). pii: E1969. doi: 10.3390/ijms18091969.

18.

Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients.

Kurozumi A, Okada Y, Arao T, Kobayashi T, Masuda D, Yamashita S, Tanaka Y.

J Diabetes Investig. 2018 Mar;9(2):360-365. doi: 10.1111/jdi.12739. Epub 2017 Oct 3.

19.

Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.

Arai T, Okato A, Kojima S, Idichi T, Koshizuka K, Kurozumi A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2017 Oct;108(10):2088-2101. doi: 10.1111/cas.13331. Epub 2017 Aug 19.

20.

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.

Goto Y, Kurozumi A, Arai T, Nohata N, Kojima S, Okato A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.

Br J Cancer. 2017 Jul 25;117(3):409-420. doi: 10.1038/bjc.2017.191. Epub 2017 Jun 22.

21.

Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.

Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A, Kato M, Katada K, Okamoto Y, Seki N.

Cancer Sci. 2017 Aug;108(8):1681-1692. doi: 10.1111/cas.13298. Epub 2017 Jul 4.

22.

Dual strands of pre-miR‑150 (miR‑150‑5p and miR‑150‑3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer.

Okato A, Arai T, Kojima S, Koshizuka K, Osako Y, Idichi T, Kurozumi A, Goto Y, Kato M, Naya Y, Ichikawa T, Seki N.

Int J Oncol. 2017 Jul;51(1):245-256. doi: 10.3892/ijo.2017.4008. Epub 2017 May 17.

PMID:
28534948
23.

Clinical Features of Patients with Basedow's Disease and High Serum IgG4 Levels.

Torimoto K, Okada Y, Kurozumi A, Narisawa M, Arao T, Tanaka Y.

Intern Med. 2017;56(9):1009-1013. doi: 10.2169/internalmedicine.56.7824. Epub 2017 May 1.

24.

Twenty-four-hour variations in blood glucose level in Japanese type 2 diabetes patients based on continuous glucose monitoring.

Hajime M, Okada Y, Mori H, Otsuka T, Kawaguchi M, Miyazaki M, Kuno F, Sugai K, Sonoda S, Tanaka K, Kurozumi A, Narisawa M, Torimoto K, Arao T, Tanaka Y.

J Diabetes Investig. 2018 Jan;9(1):75-82. doi: 10.1111/jdi.12680. Epub 2017 May 31.

25.
26.
27.

Comparative analysis of the effects of alogliptin and vildagliptin on glucose metabolism in type 2 diabetes mellitus.

Tanaka K, Okada Y, Mori H, Miyazaki M, Kuno F, Sonoda S, Sugai K, Hajime M, Kurozumi A, Narisawa M, Torimoto K, Arao T, Mine S, Tanaka Y.

Endocr J. 2017 Feb 27;64(2):179-189. doi: 10.1507/endocrj.EJ16-0341. Epub 2016 Nov 12.

28.

Excess Visceral Adipose Tissue Worsens the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus.

Kurozumi A, Okada Y, Arao T, Tanaka Y.

Intern Med. 2016;55(21):3091-3095. Epub 2016 Nov 1.

29.

Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.

Osako Y, Seki N, Kita Y, Yonemori K, Koshizuka K, Kurozumi A, Omoto I, Sasaki K, Uchikado Y, Kurahara H, Maemura K, Natsugoe S.

Int J Oncol. 2016 Dec;49(6):2255-2264. doi: 10.3892/ijo.2016.3745. Epub 2016 Oct 21.

30.

The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.

Fukumoto I, Koshizuka K, Hanazawa T, Kikkawa N, Matsushita R, Kurozumi A, Kato M, Okato A, Okamoto Y, Seki N.

Int J Oncol. 2016 Sep;49(3):1119-29. doi: 10.3892/ijo.2016.3602. Epub 2016 Jul 4.

PMID:
27573718
31.

The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma.

Goto Y, Kurozumi A, Nohata N, Kojima S, Matsushita R, Yoshino H, Yamazaki K, Ishida Y, Ichikawa T, Naya Y, Seki N.

Oncotarget. 2016 Sep 13;7(37):59070-59086. doi: 10.18632/oncotarget.10887.

32.

Factors influencing inter-day glycemic variability in diabetic outpatients receiving insulin therapy.

Mori H, Okada Y, Kurozumi A, Narisawa M, Tanaka Y.

J Diabetes Investig. 2017 Jan;8(1):69-74. doi: 10.1111/jdi.12551. Epub 2016 Aug 18.

33.

Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.

Kurozumi A, Goto Y, Okato A, Ichikawa T, Seki N.

J Hum Genet. 2017 Jan;62(1):49-56. doi: 10.1038/jhg.2016.84. Epub 2016 Jun 30. Review.

PMID:
27357429
34.

Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.

Kato M, Kurozumi A, Goto Y, Matsushita R, Okato A, Nishikawa R, Fukumoto I, Koshizuka K, Ichikawa T, Seki N.

J Hum Genet. 2017 Jan;62(1):123-132. doi: 10.1038/jhg.2016.68. Epub 2016 Jun 9.

PMID:
27278788
35.

Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report.

Kurozumi A, Okada Y, Arao T, Miyazaki Y, Yoshikawa M, Torimoto K, Kubo S, Nakayamada S, Tanaka Y.

Endocrinol Diabetes Metab Case Rep. 2016;2016:160020. doi: 10.1530/EDM-16-0020. Epub 2016 May 1.

36.

Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer.

Okato A, Goto Y, Kurozumi A, Kato M, Kojima S, Matsushita R, Yonemori M, Miyamoto K, Ichikawa T, Seki N.

Int J Oncol. 2016 Jul;49(1):111-22. doi: 10.3892/ijo.2016.3522. Epub 2016 May 16.

37.

Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.

Goto Y, Kojima S, Kurozumi A, Kato M, Okato A, Matsushita R, Ichikawa T, Seki N.

Br J Cancer. 2016 May 10;114(10):1135-44. doi: 10.1038/bjc.2016.95. Epub 2016 Apr 12.

38.

Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.

Kurozumi A, Kato M, Goto Y, Matsushita R, Nishikawa R, Okato A, Fukumoto I, Ichikawa T, Seki N.

Int J Oncol. 2016 May;48(5):1837-46. doi: 10.3892/ijo.2016.3440. Epub 2016 Mar 15.

39.

Detrimental effects of high-fat diet loading on vascular endothelial function and therapeutic efficacy of ezetimibe and statins in patients with type 2 diabetes.

Kurozumi A, Okada Y, Mori H, Kobayashi T, Masuda D, Yamashita S, Tanaka Y.

Endocr J. 2016 May 31;63(5):431-40. doi: 10.1507/endocrj.EJ15-0623. Epub 2016 Feb 3.

40.

Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.

Kurozumi A, Goto Y, Matsushita R, Fukumoto I, Kato M, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa T, Seki N.

Cancer Sci. 2016 Jan;107(1):84-94. doi: 10.1111/cas.12842. Epub 2015 Dec 5.

41.

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Fukumoto I, Kikkawa N, Matsushita R, Kato M, Kurozumi A, Nishikawa R, Goto Y, Koshizuka K, Hanazawa T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

J Hum Genet. 2016 Feb;61(2):109-18. doi: 10.1038/jhg.2015.120. Epub 2015 Oct 22.

PMID:
26490187
42.

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.

Goto Y, Kojima S, Nishikawa R, Kurozumi A, Kato M, Enokida H, Matsushita R, Yamazaki K, Ishida Y, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Br J Cancer. 2015 Sep 29;113(7):1055-65. doi: 10.1038/bjc.2015.300. Epub 2015 Sep 1.

43.

Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis.

Arao T, Okada Y, Torimoto K, Kurozumi A, Narisawa M, Yamamoto S, Tanaka Y.

J UOEH. 2015 Jun 1;37(2):103-10. doi: 10.7888/juoeh.37.103.

44.

MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.

Kato M, Goto Y, Matsushita R, Kurozumi A, Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa T, Seki N.

Int J Oncol. 2015 Aug;47(2):710-8. doi: 10.3892/ijo.2015.3043. Epub 2015 Jun 10.

PMID:
26063484
45.

MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.

Nishikawa R, Goto Y, Kurozumi A, Matsushita R, Enokida H, Kojima S, Naya Y, Nakagawa M, Ichikawa T, Seki N.

Int J Urol. 2015 Sep;22(9):867-77. doi: 10.1111/iju.12829. Epub 2015 Jun 7.

46.

[Vascular Calcification - Pathological Mechanism and Clinical Application - . Bisphosphonates for vascular calcification].

Kurozumi A, Okada Y, Nakano K, Tanaka Y.

Clin Calcium. 2015 May;25(5):723-8. doi: CliCa1505723728. Review. Japanese.

PMID:
25926576
47.

[Case of graves' disease with remarkable psychiatric symptoms].

Kuno F, Okada Y, Arao T, Kurozumi A, Tanaka Y.

J UOEH. 2015 Mar 1;37(1):49-53. doi: 10.7888/juoeh.37.49. Japanese.

48.

Functional significance of aberrantly expressed microRNAs in prostate cancer.

Goto Y, Kurozumi A, Enokida H, Ichikawa T, Seki N.

Int J Urol. 2015 Mar;22(3):242-52. doi: 10.1111/iju.12700. Epub 2015 Jan 20. Review.

49.

Induction of thyroid remission using rituximab in a patient with type 3 autoimmune polyglandular syndrome including Graves' disease and type 1 diabetes mellitus: a case report.

Kurozumi A, Okada Y, Arao T, Narisawa M, Torimoto K, Yamamoto S, Tanaka Y.

Endocr J. 2015;62(1):69-75. doi: 10.1507/endocrj.EJ14-0152. Epub 2014 Oct 1.

50.

Effect of occlusal rehabilitation on spatial memory and hippocampal neurons after long-term loss of molars in rats.

Sakamoto S, Hara T, Kurozumi A, Oka M, Kuroda-Ishimine C, Araki D, Iida S, Minagi S.

J Oral Rehabil. 2014 Oct;41(10):715-22. doi: 10.1111/joor.12198. Epub 2014 Jun 7.

PMID:
24909970

Supplemental Content

Loading ...
Support Center